Three Dimensional Pharmacophore Modelling of Monoamine oxidase-A (MAO-A) inhibitors
Abstract
:1. Introduction
2. Computational Method
Docking
3. Results and Discussion
Enrichment factor analysis
Docking
4. Conclusion
Supplementary Information
Structure | Reference | ||
---|---|---|---|
1 | MAOB specific | Eur. J. Med. Chem.1995, 30, 471–482 | |
2 | Eur. J. Med. Chem.1995, 30, 471–482 | ||
3 | Eur. J. Med. Chem.1995, 30, 471–482 | ||
4 | J. Enzyme Inhib. Med. Chem.2003, 18, 339–347 | ||
5 | J. Med. Chem.1992, 35, 3705–3713 | ||
6 | J. Med. Chem.1993, 36, 1157–1167 | ||
7 | J. Med. Chem.1993, 36, 1157–1167 | ||
8 | J. Med. Chem.1993, 36, 1157–1167 | ||
9 | J. Med. Chem.1993, 36, 1157–1167 | ||
10 | J. Med. Chem.1995, 38, 4786–4792 | ||
11 | MAOA Specific | J. Med. Chem.2004, 47, 3455–3461 | |
12 | J. Med. Chem.1994, 37, 2085–2089 | ||
13 | J. Med. Chem.1994, 37, 2085–2089 | ||
14 | J. Med. Chem.1994, 37, 2085–2089 | ||
15 | J. Med. Chem.1993, 36, 1157–1167 | ||
16 | J. Med. Chem.1991, 34, 2931–2933 | ||
17 | J. Med. Chem.1991, 34, 2931–2933 | ||
18 | J. Med. Chem.2005, 48, 2407–2419 | ||
19 | Bioorg. Med. Chem. Lett.1994, 4, 1195–1198 | ||
20 | J. Med. Chem.1998, 41, 2118–2125 | ||
21 | J. Med. Chem.1998, 41, 2118–2125 | ||
22 | Eur. J. Med. Chem.1999, 34, 137–151 | ||
23 | J. Med. Chem.1997, 40, 2466–2473 | ||
24 | J. Med. Chem.1996, 39, 1857–1863 | ||
25 | Mixed | J. Med. Chem.1996, 39, 1857–1863 | |
26 | J. Med. Chem.2002, 45, 5260–5279 | ||
27 | J. Med. Chem.1994, 37, 2085–2089 | ||
28 | J. Med. Chem.1994, 37, 2085–2089 | ||
29 | J. Med. Chem.1994, 37, 2085–2089 | ||
30 | J. Enzyme Inhib. Med. Chem.2003, 18, 339–347 | ||
31 | J. Enzyme Inhib. Med. Chem.2003, 18, 339–347 | ||
32 | J. Enzyme Inhib. Med. Chem.2003, 18, 339–347 | ||
33 | J. Med. Chem.2004, 47, 3455–3461 | ||
34 | J. Med. Chem.2004, 47, 3455–3461 | ||
35 | J. Med. Chem.2005, 48, 664–670 | ||
36 | J. Med. Chem.2005, 48, 664–670 | ||
37 | J. Med. Chem.2005, 48, 2407–2419 | ||
38 | J. Med. Chem.2005, 48, 2407–2419 | ||
39 | J. Med. Chem.2005, 48, 2407–2419 | ||
40 | J. Med. Chem.2005, 48, 2407–2419 | ||
41 | J. Med. Chem.2005, 48, 2407–2419 | ||
42 | J. Med. Chem.2005, 48, 2407–2419 | ||
43 | J. Med. Chem.2005, 48, 2407–2419 | ||
44 | J. Med. Chem.2005, 48, 2407–2419 | ||
45 | J. Med. Chem.2005, 48, 2407–2419 | ||
46 | J. Med. Chem.2005, 48, 2407–2419 | ||
47 | J. Med. Chem.2005, 48, 2407–2419 | ||
48 | Bioorg. Med. Chem. Lett.1994, 4, 1195–1198 | ||
49 | Bioorg. Med. Chem. Lett.1994, 4, 1195–1198 | ||
50 | Bioorg. Med. Chem. Lett.1994, 4, 1195–1198 | ||
51 | Bioorg. Med. Chem. Lett.1994, 4, 1195–1198 | ||
52 | J. Med. Chem.2002, 45, 5260–5279 | ||
53 | J. Med. Chem.2002, 45, 5260–5279 | ||
54 | J. Med. Chem.2002, 45, 5260–5279 | ||
55 | J. Med. Chem.2002, 45, 5260–5279 | ||
56 | J. Med. Chem.2002, 45, 5260–5279 | ||
57 | J. Med. Chem.1995, 38, 3874–3883 | ||
58 | J. Med. Chem.1995, 38, 3874–3883 | ||
59 | Bazinaprine | ||
60 | J. Med. Chem.1994, 37, 2085–2089 | ||
61 | J. Med. Chem.1993, 36, 1157–1167 | ||
62 | J. Med. Chem.1993, 36, 1157–1167 | ||
63 | J. Med. Chem.1993, 36, 1157–1167 | ||
64 | J. Med. Chem.1993, 36, 1157–1167 | ||
65 | J. Med. Chem.1993, 36, 1157–1167 | ||
66 | J. Med. Chem.1992, 35, 3705–3713 | ||
67 | J. Med. Chem.1992, 35, 3705–3713 | ||
68 | J. Med. Chem.1992, 35, 3705–3713 | ||
69 | J. Med. Chem.2004, 47, 1760–1766 | ||
70 | J. Med. Chem.2004, 47, 3455–3461 | ||
71 | J. Med. Chem.2004, 47, 3455–3461 | ||
72 | J. Med. Chem.2004, 47, 3455–3461 | ||
73 | J. Med. Chem.2004, 47, 3455–3461 | ||
74 | J. Med. Chem.2004, 47, 3455–3461 | ||
75 | J. Med. Chem.2004, 47, 3455–3461 | ||
76 | J. Med. Chem.2004, 47, 3455–3461 | ||
77 | J. Med. Chem.2004, 47, 3455–3461 | ||
78 | J. Med. Chem.2004, 47, 3455–3461 | ||
79 | J. Med. Chem.2005, 48, 664–670 | ||
80 | J. Med. Chem.2005, 48, 664–670 | ||
81 | J. Med. Chem.2006, 49, 3743–3747 | ||
82 | Bioorg. Med. Chem. Lett.1996, 6, 115–120 | ||
83 | Bioorg. Med. Chem. Lett.1996, 6, 115–120 | ||
84 | Bioorg. Med. Chem. Lett.1996, 6, 115–120 | ||
85 | Bioorg. Med. Chem. Lett.1996, 6, 115–120 | ||
86 | Bioorg. Med. Chem. Lett.1996, 6, 115–120 | ||
87 | Bioorg. Med. Chem. Lett.1996, 6, 115–120 | ||
88 | Bioorg. Med. Chem. Lett.1996, 6, 115–120 | ||
89 | Bioorg. Med. Chem. Lett.1996, 6, 115–120 | ||
90 | Bioorg. Med. Chem. Lett.1996, 6, 115–120 | ||
91 | Bioorg. Med. Chem. Lett.1996, 6, 115–120 | ||
92 | Bioorg. Med. Chem. Lett.1996, 6, 115–120 | ||
93 | Bioorg. Med. Chem. Lett.1996, 6, 115–120 | ||
94 | Bioorg. Med. Chem. Lett.1994, 4, 1195–1198 | ||
95 | Bioorg. Med. Chem. Lett.1994, 4, 1195–1198 | ||
96 | Bioorg. Med. Chem. Lett.1994, 4, 1195–1198 | ||
97 | Bioorg. Med. Chem. Lett.1994, 4, 1195–1198 | ||
98 | Bioorg. Med. Chem. Lett.1994, 4, 1195–1198 | ||
99 | Bioorg. Med. Chem. Lett.1994, 4, 1195–1198 | ||
100 | Bioorg. Med. Chem. Lett.1994, 4, 1195–1198 | ||
101 | Bioorg. Med. Chem. Lett.1994, 4, 1195–1198 | ||
102 | Bioorg. Med. Chem. Lett.2001, 11, 2715–2717 | ||
103 | Bioorg. Med. Chem. Lett.2001, 11, 2715–2717 | ||
104 | Bioorg. Med. Chem. Lett.2001, 11, 2715–2717 | ||
105 | Bioorg. Med. Chem. Lett.2001, 11, 2715–2717 | ||
106 | Bioorg. Med. Chem. Lett.2001, 11, 2715–2717 | ||
107 | Bioorg. Med. Chem. Lett.2001, 11, 2715–2717 | ||
108 | Bioorg. Med. Chem. Lett.2002, 12, 2121–2123 | ||
109 | Bioorg. Med. Chem. Lett.2002, 12, 2121–2123 | ||
110 | Bioorg. Med. Chem. Lett.2002, 12, 2121–2123 | ||
111 | Bioorg. Med. Chem. Lett.2002, 12, 2121–2123 | ||
112 | Bioorg. Med. Chem. Lett.2002, 12, 2121–2123 | ||
113 | J. Med. Chem.1998, 41, 2118–2125 | ||
114 | J. Med. Chem.1998, 41, 3812–3820 | ||
115 | J. Med. Chem.1995, 38, 3874–3883 | ||
116 | J. Med. Chem.1998, 41, 3812–3820 | ||
117 | J. Med. Chem.1998, 41, 3812–3820 | ||
118 | Bioorg. Med. Chem.2004, 12, 273–279 | ||
119 | Bioorg. Med. Chem.2005, 13, 773–783 | ||
120 | Eur. J. Med. Chem.1992, 27, 45–52 | ||
121 | Eur. J. Med. Chem.1992, 27, 45–52 | ||
122 | Eur. J. Med. Chem.1992, 27, 939–948 | ||
123 | Eur. J. Med. Chem.1995, 30, 471–482 | ||
124 | Eur. J. Med. Chem.1995, 30, 471–482 | ||
125 | Eur. J. Med. Chem.1995, 30, 471–482 |
No. | Structures | No. | Structures |
---|---|---|---|
SS01 | SS09 | ||
SS02 | SS10 | ||
SS03 | SS11 | ||
SS04 | SS12 | ||
SS05 | SS13 | ||
SS06 | SS16 | ||
SS07 | SS17 | ||
SS08 | SS18a | ||
SS19 | SS20 | ||
SS21 | SS22 |
No. | Structures | No. | Structures |
---|---|---|---|
SS14 | SS24 | ||
SS15 | SS25 | ||
SS23 | SS26 |
No. | Structures | No. | Structures |
---|---|---|---|
SS27 | SS33 | ||
SS28 | SS34 | ||
SS29 | SS35 | ||
SS30 | SS36 | ||
SS31 | SS37 | ||
SS32 | SS38 | ||
SS39 | SS40 | ||
SS41 | SS42 | ||
SS43 | SS44 | ||
SS45 | SS47 | ||
SS47 | SS48 | ||
SS49 |
No. | Structures | No. | Structures |
---|---|---|---|
SS50 | SS51 | ||
SS52 | SS53 | ||
SS54 | SS55 | ||
SS56 | SS57 | ||
SS60 | SS61 | ||
SS62 | SS63 | ||
SS64 |
Sl. No. | Observed Activity | Estimated Activity |
---|---|---|
1 | 0.0000407 | 0.000039 |
2 | 0.00000676 | 0.000021 |
3 | 0.000000389 | 0.000022 |
4 | 0.0000417 | 0.00002 |
5 | 0.00000195 | 0.0000022 |
6 | 0.00000195 | 0.000018 |
7 | 0.0000234 | 0.00000031 |
8 | 0.000000126 | 0.0000022 |
9 | 0.000000192 | 0.0000023 |
10 | 0.00000158 | 0.00000041 |
11 | 0.000001 | 0.000002 |
12 | 0.00000355 | 0.0000014 |
13 | 0.00000158 | 0.0000016 |
14 | 0.00000158 | 0.00003 |
15 | 0.0000162 | 0.000026 |
16 | 0.00000676 | 0.0000014 |
17 | 0.00000138 | 0.00000036 |
18 | 0.0000000758 | 0.0000026 |
19 | 0.000000562 | 0.00000018 |
20 | 0.0000000707 | 0.000000096 |
21 | 0.000112 | 0.0000022 |
22 | 0.00000933 | 0.0000023 |
23 | 0.000000407 | 0.000012 |
24 | 0.0000218 | 0.000027 |
25 | 0.0000398 | 0.000023 |
26 | 0.00000363 | 0.000027 |
27 | 0.000102 | 0.00000013 |
28 | 0.00000229 | 0.00000046 |
29 | 0.000000416 | 0.00000025 |
30 | 0.00000331 | 0.00000034 |
31 | 0.000000416 | 0.00000024 |
32 | 0.00000151 | 0.000000066 |
33 | 0.00000588 | 0.00000037 |
34 | 0.000001 | 0.000000064 |
35 | 0.00000707 | 0.00000045 |
36 | 0.000000575 | 0.00000044 |
37 | 0.00000122 | 0.00000029 |
38 | 0.00000191 | 0.00000011 |
39 | 0.000000218 | 0.00000026 |
40 | 0.0000000758 | 0.00000012 |
41 | 0.00000371 | 0.00000021 |
42 | 0.000000123 | 0.000000093 |
43 | 0.000000123 | 0.00000011 |
44 | 0.0000001 | 0.00000036 |
45 | 0.000000831 | 0.00000044 |
46 | 0.000000123 | 0.00000065 |
47 | 0.000000676 | 0.0000002 |
48 | 0.000000114 | 0.00000059 |
49 | 0.000000181 | 0.00000045 |
50 | 0.000000691 | 0.00000031 |
51 | 0.000000229 | 0.00000027 |
52 | 0.00000019 | 0.0000002 |
53 | 0.000000208 | 0.0000002 |
54 | 0.000000501 | 0.00000018 |
55 | 0.000000257 | 0.000039 |
56 | 0.0000151 | 0.00003 |
57 | 0.000012 | 0.00003 |
60 | 0.0000000676 | 0.00000007 |
61 | 0.0000000602 | 0.000000039 |
62 | 0.0000000288 | 0.000000037 |
63 | 0.0000000199 | 0.000000036 |
64 | 0.0000000301 | 0.000000016 |
Acknowledgement
Reference
- Geha, R.M.; Chen, K.; Wouters, J.; Ooms, F.; Shih, J.C. Analysis of conserved active site residues in monoamine oxidase A and B and their three-dimensional molecular modeling. J. Biol. Chem 2002, 277, 17209–17216. [Google Scholar]
- Gnerre, C.; Catto, M.; Leonetti, F.; Weber, P.; Carrupt, P.A.; Altomare, C.; Carotti, A.; Testa, B. Inhibition of monoamine oxidases by functionalized coumarin derivatives: biological activities, QSARs, and 3D-QSARs. J. Med. Chem 2000, 43, 4747–4758. [Google Scholar]
- Chimenti, F.; Secci, D.; Bolasco, A.; Chimenti, P.; Granese, A.M; Befani, O.; Turini, P.; Alcaro, S.; Ortuso, F. Inhibition of monoamine oxidases by coumarin-3-acyl derivatives: biological activity and computational study. Bioorg. Med. Chem. Lett 2004, 14, 3697–3703. [Google Scholar]
- CATALYST; Accelrys Inc: San Diego, CA.
- Cerius2; Accelrys Inc: San Diego, CA.
- Santana, L.; Uriarte, E.; Diaz, H. G.; Zagotto, G.; Otero, R.S.; Alvarez, E.M. A QSAR model for in silico screening of MAO-A inhibitors. Prediction, synthesis, and biological assay of novel coumarins. J. Med. Chem 2006, 49, 1149–1156. [Google Scholar]
- Parada, M.R.; Fierro, A.; Vasquez, P. I.; Cassels, B.K. A QSAR model for in silico screening of MAO-A inhibitors. Prediction, synthesis, and biological assay of novel coumarins. Curr. Enz. Inhib 2005, 1, 85–95. [Google Scholar]
© 2007 by MDPI Reproduction is permitted for noncommercial purposes.
Share and Cite
Sairam, K.V.V.M.; Khar, R.K.; Mukherjee, R.; Jain, S.K. Three Dimensional Pharmacophore Modelling of Monoamine oxidase-A (MAO-A) inhibitors. Int. J. Mol. Sci. 2007, 8, 894-919. https://doi.org/10.3390/i8090894
Sairam KVVM, Khar RK, Mukherjee R, Jain SK. Three Dimensional Pharmacophore Modelling of Monoamine oxidase-A (MAO-A) inhibitors. International Journal of Molecular Sciences. 2007; 8(9):894-919. https://doi.org/10.3390/i8090894
Chicago/Turabian StyleSairam, Kalapatapu V.V.M., Roop K. Khar, Rama Mukherjee, and Swatantra K. Jain. 2007. "Three Dimensional Pharmacophore Modelling of Monoamine oxidase-A (MAO-A) inhibitors" International Journal of Molecular Sciences 8, no. 9: 894-919. https://doi.org/10.3390/i8090894
APA StyleSairam, K. V. V. M., Khar, R. K., Mukherjee, R., & Jain, S. K. (2007). Three Dimensional Pharmacophore Modelling of Monoamine oxidase-A (MAO-A) inhibitors. International Journal of Molecular Sciences, 8(9), 894-919. https://doi.org/10.3390/i8090894